Literature DB >> 29454516

Immunity against measles, mumps, rubella, varicella, diphtheria, tetanus, polio, hepatitis A and hepatitis B among adult asylum seekers in the Netherlands, 2016.

Gudrun S Freidl1, Alma Tostmann2, Moud Curvers3, Wilhelmina L M Ruijs3, Gaby Smits3, Rutger Schepp3, Erwin Duizer3, Greet Boland4, Hester de Melker3, Fiona R M van der Klis3, Jeannine L A Hautvast2, Irene K Veldhuijzen5.   

Abstract

Asylum seekers are a vulnerable population for contracting infectious diseases. Outbreaks occur among children and adults. In the Netherlands, asylum seeker children are offered vaccination according to the National Immunization Program. Little is known about protection against vaccine-preventable diseases (VPD) in adult asylum seekers. In this 2016 study, we assessed the immunity of adult asylum seekers against nine VPD to identify groups that might benefit from additional vaccinations. We invited asylum seekers from Syria, Iran, Iraq, Afghanistan, Eritrea and Ethiopia to participate in a serosurvey. Participants provided informed consent and a blood sample, and completed a questionnaire. We measured prevalence of protective antibodies to measles, mumps, rubella, varicella, diphtheria, tetanus, polio type 1-3 and hepatitis A and B, stratified them by country of origin and age groups. The median age of the 622 participants was 28 years (interquartile range: 23-35), 81% were male and 48% originated from Syria. Overall, seroprotection was 88% for measles (range between countries: 83-93%), 91% for mumps (81-95%), 94% for rubella (84-98%), 96% for varicella (92-98%), 82% for diphtheria (65-88%), 98% for tetanus (86-100%), 91% (88-94%) for polio type 1, 95% (90-98%) for polio type 2, 82% (76-86%) for polio type 3, 84% (54-100%) for hepatitis A and 27% for hepatitis B (anti-HBs; 8-42%). Our results indicate insufficient protection against certain VPD in some subgroups. For all countries except Eritrea, measles seroprotection was below the 95% threshold required for elimination. Measles seroprevalence was lowest among adults younger than 25 years. In comparison, seroprevalence in the Dutch general population was 96% in 2006/07. The results of this study can help prioritizing vaccination of susceptible subgroups of adult asylum seekers, in general and in outbreak situations.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Asylum seekers; Immunity; Refugees; Seroprevalence; Serosurvey; Vaccine-preventable diseases

Mesh:

Substances:

Year:  2018        PMID: 29454516     DOI: 10.1016/j.vaccine.2018.01.079

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses.

Authors:  Petra Zimmermann; Kirsten P Perrett; Nicole L Messina; Susan Donath; Nicole Ritz; Fiona R M van der Klis; Nigel Curtis
Journal:  EClinicalMedicine       Date:  2019-07-26

2.  Asylum seekers' perspectives on vaccination and screening policies after their arrival in Greece and The Netherlands.

Authors:  Christina Louka; Elizabeth Chandler; Adelita V Ranchor; Hans Broer; Spyros Pournaras; Sofanne J Ravensbergen; Ymkje Stienstra
Journal:  PLoS One       Date:  2019-12-26       Impact factor: 3.240

3.  Immunity status against tetanus in young migrants: a seroprevalence study.

Authors:  Paola Affanni; Maria Eugenia Colucci; Emanuela Capobianco; Maria Teresa Bracchi; Roberta Zoni; Isabella Viani; Luca Caruso; Lucrezia Carlone; Carlo Arcuri; Licia Veronesi
Journal:  Acta Biomed       Date:  2020-04-10

4.  Disease burden in a large cohort of asylum seekers and refugees in Germany.

Authors:  Frank Müller; Evelyn Kleinert; Nele Hillermann; Anne Simmenroth; Eva Hummers; Anna Zychlinsky Scharff; Christian Dopfer; Christine Happle; Alexandra Jablonka
Journal:  J Glob Health       Date:  2021-01-30       Impact factor: 4.413

5.  Meningococcal infections among refugees and immigrants: silent threats of past, present and future.

Authors:  Ener Cagri Dinleyici; Ray Borrow
Journal:  Hum Vaccin Immunother       Date:  2020-04-29       Impact factor: 3.452

6.  Interventions to Improve Vaccination Uptake and Cost Effectiveness of Vaccination Strategies in Newly Arrived Migrants in the EU/EEA: A Systematic Review.

Authors:  Charles Hui; Jessica Dunn; Rachael Morton; Lukas P Staub; Anh Tran; Sally Hargreaves; Christina Greenaway; Beverly Ann Biggs; Robin Christensen; Kevin Pottie
Journal:  Int J Environ Res Public Health       Date:  2018-09-20       Impact factor: 3.390

7.  Public health response to large influx of asylum seekers: implementation and timing of infectious disease screening.

Authors:  Paula Tiittala; Karolina Tuomisto; Taneli Puumalainen; Outi Lyytikäinen; Jukka Ollgren; Olli Snellman; Otto Helve
Journal:  BMC Public Health       Date:  2018-09-24       Impact factor: 3.295

8.  Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand.

Authors:  Teeraporn Chinchai; Nawarat Posuwan; Viboonsak Vuthitanachot; Nasamon Wanlapakorn; Yong Poovorawan
Journal:  J Health Popul Nutr       Date:  2019-10-18       Impact factor: 2.000

Review 9.  Whole Genome Sequencing for Surveillance of Diphtheria in Low Incidence Settings.

Authors:  Helena M B Seth-Smith; Adrian Egli
Journal:  Front Public Health       Date:  2019-08-21

10.  Health of Special Immigrant Visa holders from Iraq and Afghanistan after arrival into the United States using Domestic Medical Examination data, 2014-2016: A cross-sectional analysis.

Authors:  Gayathri S Kumar; Clelia Pezzi; Simone Wien; Blain Mamo; Kevin Scott; Colleen Payton; Kailey Urban; Stephen Hughes; Lori Kennedy; Nuny Cabanting; Jessica Montour; Melissa Titus; Jenny Aguirre; Breanna Kawasaki; Rebecca Ford; Emily S Jentes
Journal:  PLoS Med       Date:  2020-03-31       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.